日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer.

有效载荷多样化克服耐药性并指导乳腺癌的序贯抗体药物偶联疗法。

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-3321
Rampa Dileep Reddy, Seo Minji, Ogata Nanae, Yang Zhaoxuan, Sridhar Nithya, Fujii Takeo, Wannaphut Chalothorn, Maynard Jennifer A, Tsuchikama Kyoji, Sledge George W Jr, Ueno Naoto T, Lee Jangsoon
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals

真实世界证据为不依赖组织来源的治疗审批提供了临床见解

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-57941-0
Sledge, George W Jr; Yoshino, Takayuki; Xiu, Joanne; Helmstetter, Anthony; Ribeiro, Jennifer R; Klimov, Sergey; Gilg, Brady; Gao, J J; Elton, Jeff; Oberley, Matthew J; Radovich, Milan; Abraham, Jim; Spetzler, David
发表日期：2025
文献求助 收藏

Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysis

曲妥珠单抗德鲁西替康与沙妥珠单抗戈维替康在HER2阴性转移性乳腺癌中的比较：一项大型真实世界数据分析

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-02094-7
Sledge, George W Jr; Xiu, Joanne; Solzak, Jeffrey Peter; Ribeiro, Jennifer; Mahtani, Reshma L; Lustberg, Maryam B; Oberley, Matthew J; Radovich, Milan; Spetzler, David
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108

单药他莫昔芬治疗转移性乳腺癌患者的CYP2D6活性：ECOG-ACRIN E3108研究结果

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-024-07519-z
Stearns, Vered; ONeill, Anne; Schneider, Bryan P; Skaar, Todd C; Liu, Minetta C; Lohrisch, Caroline; Goetz, Matthew P; Vallejos, Carlos S; Sparano, Joseph A; Villa, Diego; Silverman, Paula; Cheema, Puneet S; Moore, Dennis F Jr; Sledge, George W Jr
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Etirinotecan Pegol (NKTR-102) in Patients With Active Brain Metastases From Lung or Breast Cancer

依替尼康聚乙二醇（NKTR-102）用于治疗肺癌或乳腺癌脑转移患者

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.70330
Nagpal, Seema; Nguyen, Kim-Son; Bertrand, Sophie; Cunanan, Kristen May; Padda, Sukhmani K; Pagtama, Judy Y; Tisch, Alison Holmes; Coffey, Gwen; Thomas, Reena P; Sledge, George W Jr; Gruber, Joshua; Telli, Melinda L; Pegram, Mark; Recht, Lawrence D; Wakelee, Heather A; Soltys, Scott G; Massarweh, Suleiman A; Neal, Joel W
肺癌
肿瘤
肿瘤免疫
神经科学
乳腺癌
发表日期：2025
文献求助 收藏

Dual inhibition of EGFR and PI3Kinase signaling in EGFR amplified triple negative breast cancer cells induces apoptosis and reduces tumor growth.

在 EGFR 扩增的三阴性乳腺癌细胞中，同时抑制 EGFR 和 PI3Kinase 信号传导可诱导细胞凋亡并减少肿瘤生长

期刊:
影响因子:
doi:10.1101/2025.06.03.657674
Wisniewski David J, Voeller Donna, Addissie Yonit A, Deshmukh Sachin Kumar, Wu Sharon, Lustberg Maryam B, Wangsa Darawalee, Wangsa Danny, Heselmeyer-Haddad Kerstin, Sledge George W Jr, Lipkowitz Stanley
信号转导
细胞生物学
肿瘤
乳腺癌
Apoptosis
EGFR
凋亡
发表日期：2025
文献求助 收藏

Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumors

转移性结直肠癌的共识性分子分型扩大了生物标志物指导的治疗对CMS1和CMS2肿瘤患者的益处

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-024-02826-0
Chowdhury, Saikat; Xiu, Joanne; Ribeiro, Jennifer R; Nicolaides, Theodore; Zhang, Jian; Korn, W Michael; Poorman, Kelsey A; Lenz, Heinz-Josef; Marshall, John L; Oberley, Matthew J; Sledge, George W Jr; Spetzler, David; Kopetz, Scott; Shen, John Paul
肿瘤
肠癌
肿瘤免疫
多发性硬化症
发表日期：2024
文献求助 收藏

Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted Therapy

恶性叶状肿瘤的基因组图谱揭示了靶向治疗的亚群

期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO.24.00289
Bansal, Rani; Adeyelu, Tolulope; Elliott, Andrew; Tan, Antoinette R; Ribeiro, Jennifer R; Meisel, Jane; Oberley, Matthew J; Graff, Stephanie L; Sledge, George W Jr; Grilley-Olson, Juneko E; Sammons, Sarah L; Rosenberger, Laura H
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Abemaciclib plus fulvestrant in East Asian women with HR+, HER2- advanced breast cancer: Overall survival from MONARCH 2

阿贝西利联合氟维司群治疗东亚HR+、HER2-晚期乳腺癌女性患者：MONARCH 2研究的总生存期

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.15600
Toi, Masakazu; Huang, Chiun-Sheng; Im, Young-Hyuck; Sohn, Joohyuk; Zhang, Wei; Sakaguchi, Sachi; Haddad, Nadine; van Hal, Gertjan; Sledge, George W Jr
肿瘤
HER2
肿瘤免疫
乳腺癌
ARC
发表日期：2023
文献求助 收藏

Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer

肿瘤突变负荷高乳腺癌中免疫反应性肿瘤微环境的并发预测因子

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1235902
Sammons, Sarah; Elliott, Andrew; Barroso-Sousa, Romualdo; Chumsri, Saranya; Tan, Antoinette R; Sledge, George W Jr; Tolaney, Sara M; Torres, Evanthia T Roussos
肿瘤
肿瘤免疫
乳腺癌
肿瘤微环境
免疫/内分泌
发表日期：2023
文献求助 收藏